Contacter le RP
Pour utiliser cette fonctionnalité, vous devez bénéficier d'un compte Babbler.
Babbler permet aux journalistes et communicants de collaborer plus simplement.
En vous connectant, vous pourrez accéder gratuitement aux espaces presse des centaines d'entreprises de vos secteurs qui sont sur Babbler, entrer en contact direct avec leurs équipes RP mais aussi y partager vos prochains sujets !
Leurs espaces presse sont sur Babbler :
Vous êtes à 1 clic de l'inscription !
Content de vous revoir !
Conjunctivitis Drugs Market to enroll appeal rate by 2022
minutes de lecture
minute de lecture
The report of Global Conjunctivitis Drugs Market of Market Research Future comprises extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts and key opinion leaders to gain a deeper insight of the market and industry performance. Conjunctivitis, or pink eye, is inflammation of the outermost layer of the white part of the eye and the inner surface of the eyelid due to numerous causes the most common being bacterial infection. The condition is self-limiting, but in some cases results in kerato-conjunctivitis, which results in blurred vision. The viral and bacterial conjunctivitis results in highly infectious watery discharge which is extremely contagious.
The market for conjunctivitis is growing at a moderate rate. The growth factors for the growth of global conjunctivitis drugs market are rise in hygiene and awareness, growing expenditure on health, greater exposure to allergens and infective agents, the contagious nature of the disease etc. However the market is restrained by many factors such as the self-limiting nature of the disease, off label drug use, greater fragmentation of the market and penetration of generics etc. However the most important reason is loss of patents on a number of market leaders such as Moxeza, Besivance, Vigamox, and Zymaxid. The lack of specific treatment for allergic conjunctivitis and self-limiting and non-life threatening nature of the treatment also acts as a constraint.
Taking all these factors together, we expect the Global Conjunctivitis Drugs Market to reach around US$ 1.08 billion by the end of the forecast period and is expected to grow at a CAGR of ~3.1%.
Key Players for Global Conjunctivitis Drugs Market:
Some of the key players in this market are: Akorn Pharmaceuticals, Alcon/ Novartis AG, Allergan Plc, Bausch & Lomb, Valeant Pharmaceuticals, Merck & Co. Inc., Actavis Plc., Pfizer Inc. and others.
Get Sample Copy at https://www.marketresearchfuture.com/sample_request/2513 .
Global conjunctivitis drugs market has been segmented on the basis of conjunctivitis type which comprises of viral, bacterial, allergic and others types of the same. On the basis of drug class; market is segmented into antibiotics (quinolones, aminoglycosides, macrolides and others), mast cell stabilizers, steroids and others. On the basis of route of administration; the market is segmented into topical, oral and intravitreal. On the basis of end users; market is segmented into hospitals and self-administered.
Regional Analysis of Global Conjunctivitis Drugs Market:
Globally America is the largest market for conjunctivitis drugs followed by Europe. However both these markets are saturated and stagnant. The future growth will be ushered by Asia Pacific region closely followed by Middle East and African market. The growth will be largely led by unmet medical needs.
Table Of Contents
2 Research Methodology
3 Market Dynamics
4 Market Factor Analysis
5 Global Conjunctivitis Drugs Market, By Conjunctivitis Type
6 Global Conjunctivitis Drugs Market, By Drug Class
7 Global Conjunctivitis Drugs Market, By Route Of Administration
8 Global Conjunctivitis Drugs Market, By End Users
9 Global Conjunctivitis Drugs Market, By Regions
10 Company Landscape
11 Company Profile
Access for Discount @ https://www.marketresearchfuture.com/check-discount/2513 .
Top Reasons to Buy the Reports:
- Company profiling with detailed strategies, financials, and recent development activities
- Market Strategic Business Influence Data
- Market Research Future recommendations in key business segments based on the market estimations
- Market share analysis of the top industry players
- Market forecasts for a minimum of 5 years of all the mentioned segments, Trends and the regional markets With SWOT Analysis
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
+1 646 845 9312
- Health & Medicine
Autres actualités de la marque
Félicitations, vous êtes inscrit sur BABBLER !
Pour découvrir dès maintenant toutes les actualités qui vous attendent sur Babbler, consultez votre newsfeed !
Vos domaines ont été préselectionnés. Vous pouvez les compléter en cliquant ici
- Health & Medicine